Glaxosmithkline Plc Adr Stock Price on November 14, 2024
| GSK Stock | USD 34.13 0.20 0.58% |
Below is the normalized historical share price chart for GlaxoSmithKline PLC ADR extending back to November 05, 1984. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of GlaxoSmithKline PLC stands at 34.13, as last reported on the 30th of November, with the highest price reaching 34.20 and the lowest price hitting 33.89 during the day.
If you're considering investing in GlaxoSmithKline Stock, it is important to understand the factors that can impact its price. GlaxoSmithKline PLC ADR holds Efficiency (Sharpe) Ratio of -0.24, which attests that the entity had a -0.24% return per unit of standard deviation over the last 3 months. GlaxoSmithKline PLC ADR exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out GlaxoSmithKline PLC's risk adjusted performance of (0.18), and Market Risk Adjusted Performance of (1.31) to validate the risk estimate we provide.
At this time, GlaxoSmithKline PLC's Total Stockholder Equity is quite stable compared to the past year. Common Stock Total Equity is expected to rise to about 1.6 B this year, although the value of Capital Stock will most likely fall to about 1.3 B. . At this time, GlaxoSmithKline PLC's Price Book Value Ratio is quite stable compared to the past year. Price To Book Ratio is expected to rise to 8.65 this year, although the value of Price Earnings To Growth Ratio will most likely fall to (1.02). GlaxoSmithKline Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 9th of July 1986 | 200 Day MA 40.6796 | 50 Day MA 37.5662 | Beta 0.33 |
GlaxoSmithKline |
Sharpe Ratio = -0.241
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | GSK |
Estimated Market Risk
| 1.47 actual daily | 13 87% of assets are more volatile |
Expected Return
| -0.35 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.24 actual daily | 0 Most of other assets perform better |
Based on monthly moving average GlaxoSmithKline PLC is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of GlaxoSmithKline PLC by adding GlaxoSmithKline PLC to a well-diversified portfolio.
Price Book 3.9771 | Enterprise Value Ebitda 10.0938 | Price Sales 2.237 | Shares Float 3.9 B | Dividend Share 0.61 |
Related Headline
AstraZeneca PLC Headline on 14th of November 2024
Earnings call Invivyd reports steady growth amid regulatory ... by investing.com
Earnings call Invivyd reports steady growth amid regulatory challenges
GlaxoSmithKline PLC Valuation on November 14, 2024
It is possible to determine the worth of GlaxoSmithKline PLC on a given historical date. On November 14, 2024 GlaxoSmithKline was worth 35.0 at the beginning of the trading date compared to the closed value of 34.0. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of GlaxoSmithKline PLC stock. Still, in general, we apply an absolute valuation method to find GlaxoSmithKline PLC's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of GlaxoSmithKline PLC where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against GlaxoSmithKline PLC's related companies.
| Open | High | Low | Close | Volume | |
| 34.77 | 34.89 | 34.42 | 34.71 | 7,279,471 | |
11/14/2024 | 35.00 | 35.06 | 33.97 | 34.00 | 7,032,511 |
| 33.26 | 33.50 | 32.83 | 33.35 | 13,747,891 |
| Backtest GlaxoSmithKline PLC | | | GlaxoSmithKline PLC History | | | GlaxoSmithKline PLC Valuation | Previous | Next |
GlaxoSmithKline PLC Trading Date Momentum on November 14, 2024
| On November 15 2024 GlaxoSmithKline PLC ADR was traded for 33.35 at the closing time. Highest GlaxoSmithKline PLC's price during the trading hours was 33.50 and the lowest price during the day was 32.83 . The net volume was 13.7 M. The overall trading history on the 15th of November 2024 contributed to the next trading period price depreciation. The overall trading delta to the next next day price was 1.91% . The overall trading delta to current price is 0.15% . |
GlaxoSmithKline PLC ADR Fundamentals Correlations and Trends
By evaluating GlaxoSmithKline PLC's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among GlaxoSmithKline PLC's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. GlaxoSmithKline financial account trend analysis is a perfect complement when working with valuation or volatility modules.About GlaxoSmithKline PLC Stock history
GlaxoSmithKline PLC investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for GlaxoSmithKline is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in GlaxoSmithKline PLC ADR will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing GlaxoSmithKline PLC stock prices may prove useful in developing a viable investing in GlaxoSmithKline PLC
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 4.1 B | 4.3 B | |
| Net Income Applicable To Common Shares | 13.5 B | 14.1 B |
GlaxoSmithKline PLC Stock Technical Analysis
GlaxoSmithKline PLC technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
GlaxoSmithKline PLC Period Price Range
Low | November 30, 2024
| High |
0.00 | 0.00 |
GlaxoSmithKline PLC ADR cannot be verified against its exchange. Please verify the symbol is currently traded on New York Stock Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
GlaxoSmithKline PLC November 30, 2024 Market Strength
Market strength indicators help investors to evaluate how GlaxoSmithKline PLC stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading GlaxoSmithKline PLC shares will generate the highest return on investment. By undertsting and applying GlaxoSmithKline PLC stock market strength indicators, traders can identify GlaxoSmithKline PLC ADR entry and exit signals to maximize returns
GlaxoSmithKline PLC Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for GlaxoSmithKline PLC's price direction in advance. Along with the technical and fundamental analysis of GlaxoSmithKline Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of GlaxoSmithKline to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.18) | |||
| Jensen Alpha | (0.40) | |||
| Total Risk Alpha | (0.60) | |||
| Treynor Ratio | (1.32) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in GlaxoSmithKline PLC ADR. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of GlaxoSmithKline PLC. If investors know GlaxoSmithKline will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about GlaxoSmithKline PLC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.28) | Dividend Share 0.61 | Earnings Share 1.53 | Revenue Per Share 15.38 | Quarterly Revenue Growth (0.02) |
The market value of GlaxoSmithKline PLC ADR is measured differently than its book value, which is the value of GlaxoSmithKline that is recorded on the company's balance sheet. Investors also form their own opinion of GlaxoSmithKline PLC's value that differs from its market value or its book value, called intrinsic value, which is GlaxoSmithKline PLC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because GlaxoSmithKline PLC's market value can be influenced by many factors that don't directly affect GlaxoSmithKline PLC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between GlaxoSmithKline PLC's value and its price as these two are different measures arrived at by different means. Investors typically determine if GlaxoSmithKline PLC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, GlaxoSmithKline PLC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.